The Frontiers of Rare Disease Development: Advances in Regulatory Science with Dr. Tim Franson (Ep. 18 of The Pharmcast)

May 10, 2017 Jim Combs

 

Pharmcast_Ep18_HeroImage.png 

This week on The Pharmcast, we catch up with Dr. Tim Franson to discuss the leading edge of rare disease drug development. Dr. Franson has been actively helping Parent Project Muscular Dystrophy, a Duchenne Muscular Dystrophy Patient Advocacy group, which is doing pioneering work collaborating with FDA to inform benefit-risk and establish FDA guidance.

Duchenne has been a great test case, so we sat down with Tim to share his lessons learned and understand what’s happening on the frontiers of rare disease drug development.

If you have topics you would like YourEncore to explore on future episodes of The Pharmcast, please email Pharmcast@yourencore.com with feedback or suggestions.

The Pharmcast is now available for download on iTunes, Google Play, and Stitcher. If you like what you hear, share it with your friends and write a review or give us a rating on your podcast store. 

pharmcast_cta.png

 

Previous Article
State of the Industry: U.S. Regulatory Policy Improvements (Ep. 19 of The Pharmcast)
State of the Industry: U.S. Regulatory Policy Improvements (Ep. 19 of The Pharmcast)

  In this episode of The Pharmcast, we share a recording from our May 5th webinar, State of t...

Next Video
[WEBINAR] State of the Industry Webinar:  U.S. Regulatory Policy Improvements
[WEBINAR] State of the Industry Webinar: U.S. Regulatory Policy Improvements